OpenAlex
PricingAboutJobs
Log inGet started
Work

CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

HTML

Year: 2021
Type: article
Source: European Neurology
DOI: 10.1159/000517770
Authors: Zerrin Karaaslan, Murat Kurtuncu, Halil İbrahim Akcay, Tuncay Gunduz, Burcu Altunrende, Recai Turkoglu, Mefkure Eraksoy, Canan Ulusoy, Vuslat Yilmaz, Erdem Tüzün
Institutions: Istanbul University, Haydarpaşa Numune Eğitim ve Araştırma Hastanesi
Language: English

Topic: Multiple Sclerosis Research Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: CXCL13, fingolimod, multiple sclerosis, treatment response, biomarkers, chemokines, disease-modifying therapy
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W3188323733
FWCI: 0.386
Cites: 10
Cited by: 4
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security